首页/数据集/Immunogenicity and safety of a recombinant Omicron BA.4/5-Delta COVID-19 vaccine ZF2202-A in Chinese adults

Immunogenicity and safety of a recombinant Omicron BA.4/5-Delta COVID-19 vaccine ZF2202-A in Chinese adults

NCATS Open Data2024-08-16 更新2026-08-08 收录

疫苗临床试验

免疫原性与安全性评估

数据链接：

https://doi.org/10.1016/j.vaccine.2024.04.058 数据链接链接失效反馈

官方服务：

资源简介：

Immunogenicity and safety of a recombinant Omicron BA.4/5-Delta COVID-19 vaccine ZF2202-A in Chinese adults

应用场景：

创建时间：

2024-05-31

癌症免疫治疗

疫苗临床试验

BackgroundImmune checkpoint blockade with monoclonal antibodies targeting programmed death 1 (PD-1) and its ligand PD-L1 has played a major role in the rise of cancer immune therapy. We have identifie

NIAID Data Ecosystem70

Predictors of consenting to mucosal secretion sampling amongst volunteers screened for HVTN 097.

疫苗临床试验

生物样本采集行为预测

*OR = Odds Ratio. **95% CI = 95% confidence interval. †AOR = Adjusted Odds Ratio. Predictors of consenting to mucosal secretion sampling amongst volunteers screened for HVTN 097.

NIAID Data Ecosystem30

Dataset from Safety and Immunogenicity Study of GSK Biologicals' Candidate Tuberculosis Vaccine (692342) When Administered to Healthy Infants

疫苗临床试验

结核病预防

This purpose of the study is to assess the safety and immunogenicity of a GSK Biologicals' candidate tuberculosis vaccine (692342) when administered concomitantly with or after the Expanded Programme

NIAID Data Ecosystem20

ATN 064 Burk HPV DNA Dataset in Immunogenicity, Safety, Tolerability, and Behavioral Consequences of an HPV-6, -11, -16, -18 Vaccine in HIV-Infected Young Women

疫苗临床试验

HIV感染者免疫干预

Burk Lab HPV DNA data Study Description A Phase II, open-label, multi-center study that evaluated the immunogenicity, safety, tolerability, and behavioral impact of an HPV-6, -11, -16, -18 vaccine in

NIAID Data Ecosystem40

Characteristics of HVTN 502 and 503 trial participants.

疫苗临床试验

免疫基因型分析

Data shown are median values (interquartile range) unless otherwise indicated. * At time of sampling § HLA-B*27, B51, B*5701/03, B*5801 and B*8101 Characteristics of HVTN 502 and 503 trial participant

NIAID Data Ecosystem20

Immunogenicity and safety of a recombinant Omicron BA.4/5-Delta COVID-19 vaccine ZF2202-A in Chinese adults

资源简介：

相关数据集